Superworth

Ingevity price to free cash flow NGVT

Market value divided by free cash flow over the last twelve months, since 2017.

Today, Nov 2, 2026
16.4×
10-year median
16.5×
Against its 10-year history
50th
percentile: 0 is its lowest day, 100 its highest
10-year range
7.3× to 65.9×
Peer median
24.6×

Ingevity's price to free cash flow is 16.4× as of Nov 2, 2026.

That is below its ten-year median of 16.5×, close to the middle of its last ten years.

Over that time it ranged from 7.3× in Nov 2025 to 65.9× in Nov 2024.

The median for 10 chemicals stocks of a similar size is 24.6×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far16.4×8.2×17.3×
20259.0×7.3×64.0×
202455.1×11.5×65.9×
202313.3×10.7×21.2×
202216.4×9.1×18.5×
202110.3×10.3×15.7×
202015.7×7.3×22.3×
201922.9×22.9×35.0×
201825.7×22.3×34.1×
201722.6×22.6×37.4×

Against its peers

Companies in Chemicals nearest Ingevity's size, closest first, today.

CompanyPrice to free cash flow
NGVTIngevity16.4×
IOSPInnospec35.0×
FULFuller H B27.7×
ROGRogers23.5×
WDFCWD 4031.3×
CBTCabot13.9×
AVNTAvient20.9×
CSWCSW Industrials26.4×
CRONCronos24.6×
BCPCBalchemn/m
HXLHexcel24.0×
Peer median24.6×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Ingevity

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.